BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3118006)

  • 1. Evaluation of orally administered activated charcoal on intestinal dialysis of intravenously administered M79175, an aldose reductase inhibitor, in rats.
    Arimori K; Mishima M; Iwaoku R; Nakano M
    J Pharmacobiodyn; 1987 Jun; 10(6):243-9. PubMed ID: 3118006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corneal permeability of aldose reductase inhibitor, M79175. II. In vivo study on pharmacokinetic aspect.
    Kato A; Horie T; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):287-94. PubMed ID: 3139809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The intestinal dialysis of intravenously administered phenytoin by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1987 Apr; 10(4):157-65. PubMed ID: 3656062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.
    Kato A; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):279-86. PubMed ID: 3139808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 8. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate.
    Poulsom R
    Biochem Pharmacol; 1986 Sep; 35(17):2955-9. PubMed ID: 3091036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport of theophylline from blood to the intestinal lumen following i.v. administration to rats.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1985 Apr; 8(4):324-7. PubMed ID: 4032222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of aldose reductase from human retina.
    Poulsom R
    Curr Eye Res; 1987 Mar; 6(3):427-32. PubMed ID: 3107906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of an orally absorbed aldose reductase inhibitor, sorbinil.
    Foulds G; O'Brien MM; Bianchine JR; Gabbay KH
    Clin Pharmacol Ther; 1981 Nov; 30(5):693-700. PubMed ID: 6794971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of the aldose reductase inhibitor AL01576 in rats.
    Park YH; Wooldridge CB; Mattern J; Stoltz ML; Brazzell RK
    J Pharm Sci; 1988 Feb; 77(2):110-5. PubMed ID: 3129545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of furosemide into the intestinal lumen and the lack of effect of gastrointestinal dialysis by charcoal in rats with acute renal failure.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1988 Jan; 11(1):1-8. PubMed ID: 3385600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.